Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Underactive Bladder Market

ID: MRFR/HC/37666-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Underactive Bladder Market Research Report By Type (Pharmacological Treatments, Non-Pharmacological Treatments, Surgical Interventions), By End User (Hospitals, Clinics, Homecare Settings), By Category (Overactive Bladder Medications, Neuromodulation Devices, Supportive Therapies), By Gender (Male, Female), By Age Group (Children, Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Underactive Bladder Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Type (USD Billion) | |
      1. 4.1.1 Pharmacological Treatments | |
      2. 4.1.2 Non-Pharmacological Treatments | |
      3. 4.1.3 Surgical Interventions |
    2. 4.2 Healthcare, BY End User (USD Billion) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Clinics | |
      3. 4.2.3 Homecare Settings |
    3. 4.3 Healthcare, BY Category (USD Billion) | |
      1. 4.3.1 Overactive Bladder Medications | |
      2. 4.3.2 Neuromodulation Devices | |
      3. 4.3.3 Supportive Therapies |
    4. 4.4 Healthcare, BY Gender (USD Billion) | |
      1. 4.4.1 Male | |
      2. 4.4.2 Female |
    5. 4.5 Healthcare, BY Age Group (USD Billion) | |
      1. 4.5.1 Children | |
      2. 4.5.2 Adults | |
      3. 4.5.3 Elderly |
    6. 4.6 Healthcare, BY Region (USD Billion) | |
      1. 4.6.1 North America | | |
        1. 4.6.1.1 US | | |
        2. 4.6.1.2 Canada | |
      2. 4.6.2 Europe | | |
        1. 4.6.2.1 Germany | | |
        2. 4.6.2.2 UK | | |
        3. 4.6.2.3 France | | |
        4. 4.6.2.4 Russia | | |
        5. 4.6.2.5 Italy | | |
        6. 4.6.2.6 Spain | | |
        7. 4.6.2.7 Rest of Europe | |
      3. 4.6.3 APAC | | |
        1. 4.6.3.1 China | | |
        2. 4.6.3.2 India | | |
        3. 4.6.3.3 Japan | | |
        4. 4.6.3.4 South Korea | | |
        5. 4.6.3.5 Malaysia | | |
        6. 4.6.3.6 Thailand | | |
        7. 4.6.3.7 Indonesia | | |
        8. 4.6.3.8 Rest of APAC | |
      4. 4.6.4 South America | | |
        1. 4.6.4.1 Brazil | | |
        2. 4.6.4.2 Mexico | | |
        3. 4.6.4.3 Argentina | | |
        4. 4.6.4.4 Rest of South America | |
      5. 4.6.5 MEA | | |
        1. 4.6.5.1 GCC Countries | | |
        2. 4.6.5.2 South Africa | | |
        3. 4.6.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Astellas Pharma (JP) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Pfizer (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Boehringer Ingelheim (DE) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Santen Pharmaceutical (JP) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Eli Lilly and Company (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Novartis (CH) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 AbbVie (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Teva Pharmaceutical Industries (IL) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Ferring Pharmaceuticals (CH) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TYPE |
    7. 6.4 US MARKET ANALYSIS BY END USER |
    8. 6.5 US MARKET ANALYSIS BY CATEGORY |
    9. 6.6 US MARKET ANALYSIS BY GENDER |
    10. 6.7 US MARKET ANALYSIS BY AGE GROUP |
    11. 6.8 CANADA MARKET ANALYSIS BY TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY END USER |
    13. 6.10 CANADA MARKET ANALYSIS BY CATEGORY |
    14. 6.11 CANADA MARKET ANALYSIS BY GENDER |
    15. 6.12 CANADA MARKET ANALYSIS BY AGE GROUP |
    16. 6.13 EUROPE MARKET ANALYSIS |
    17. 6.14 GERMANY MARKET ANALYSIS BY TYPE |
    18. 6.15 GERMANY MARKET ANALYSIS BY END USER |
    19. 6.16 GERMANY MARKET ANALYSIS BY CATEGORY |
    20. 6.17 GERMANY MARKET ANALYSIS BY GENDER |
    21. 6.18 GERMANY MARKET ANALYSIS BY AGE GROUP |
    22. 6.19 UK MARKET ANALYSIS BY TYPE |
    23. 6.20 UK MARKET ANALYSIS BY END USER |
    24. 6.21 UK MARKET ANALYSIS BY CATEGORY |
    25. 6.22 UK MARKET ANALYSIS BY GENDER |
    26. 6.23 UK MARKET ANALYSIS BY AGE GROUP |
    27. 6.24 FRANCE MARKET ANALYSIS BY TYPE |
    28. 6.25 FRANCE MARKET ANALYSIS BY END USER |
    29. 6.26 FRANCE MARKET ANALYSIS BY CATEGORY |
    30. 6.27 FRANCE MARKET ANALYSIS BY GENDER |
    31. 6.28 FRANCE MARKET ANALYSIS BY AGE GROUP |
    32. 6.29 RUSSIA MARKET ANALYSIS BY TYPE |
    33. 6.30 RUSSIA MARKET ANALYSIS BY END USER |
    34. 6.31 RUSSIA MARKET ANALYSIS BY CATEGORY |
    35. 6.32 RUSSIA MARKET ANALYSIS BY GENDER |
    36. 6.33 RUSSIA MARKET ANALYSIS BY AGE GROUP |
    37. 6.34 ITALY MARKET ANALYSIS BY TYPE |
    38. 6.35 ITALY MARKET ANALYSIS BY END USER |
    39. 6.36 ITALY MARKET ANALYSIS BY CATEGORY |
    40. 6.37 ITALY MARKET ANALYSIS BY GENDER |
    41. 6.38 ITALY MARKET ANALYSIS BY AGE GROUP |
    42. 6.39 SPAIN MARKET ANALYSIS BY TYPE |
    43. 6.40 SPAIN MARKET ANALYSIS BY END USER |
    44. 6.41 SPAIN MARKET ANALYSIS BY CATEGORY |
    45. 6.42 SPAIN MARKET ANALYSIS BY GENDER |
    46. 6.43 SPAIN MARKET ANALYSIS BY AGE GROUP |
    47. 6.44 REST OF EUROPE MARKET ANALYSIS BY TYPE |
    48. 6.45 REST OF EUROPE MARKET ANALYSIS BY END USER |
    49. 6.46 REST OF EUROPE MARKET ANALYSIS BY CATEGORY |
    50. 6.47 REST OF EUROPE MARKET ANALYSIS BY GENDER |
    51. 6.48 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP |
    52. 6.49 APAC MARKET ANALYSIS |
    53. 6.50 CHINA MARKET ANALYSIS BY TYPE |
    54. 6.51 CHINA MARKET ANALYSIS BY END USER |
    55. 6.52 CHINA MARKET ANALYSIS BY CATEGORY |
    56. 6.53 CHINA MARKET ANALYSIS BY GENDER |
    57. 6.54 CHINA MARKET ANALYSIS BY AGE GROUP |
    58. 6.55 INDIA MARKET ANALYSIS BY TYPE |
    59. 6.56 INDIA MARKET ANALYSIS BY END USER |
    60. 6.57 INDIA MARKET ANALYSIS BY CATEGORY |
    61. 6.58 INDIA MARKET ANALYSIS BY GENDER |
    62. 6.59 INDIA MARKET ANALYSIS BY AGE GROUP |
    63. 6.60 JAPAN MARKET ANALYSIS BY TYPE |
    64. 6.61 JAPAN MARKET ANALYSIS BY END USER |
    65. 6.62 JAPAN MARKET ANALYSIS BY CATEGORY |
    66. 6.63 JAPAN MARKET ANALYSIS BY GENDER |
    67. 6.64 JAPAN MARKET ANALYSIS BY AGE GROUP |
    68. 6.65 SOUTH KOREA MARKET ANALYSIS BY TYPE |
    69. 6.66 SOUTH KOREA MARKET ANALYSIS BY END USER |
    70. 6.67 SOUTH KOREA MARKET ANALYSIS BY CATEGORY |
    71. 6.68 SOUTH KOREA MARKET ANALYSIS BY GENDER |
    72. 6.69 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP |
    73. 6.70 MALAYSIA MARKET ANALYSIS BY TYPE |
    74. 6.71 MALAYSIA MARKET ANALYSIS BY END USER |
    75. 6.72 MALAYSIA MARKET ANALYSIS BY CATEGORY |
    76. 6.73 MALAYSIA MARKET ANALYSIS BY GENDER |
    77. 6.74 MALAYSIA MARKET ANALYSIS BY AGE GROUP |
    78. 6.75 THAILAND MARKET ANALYSIS BY TYPE |
    79. 6.76 THAILAND MARKET ANALYSIS BY END USER |
    80. 6.77 THAILAND MARKET ANALYSIS BY CATEGORY |
    81. 6.78 THAILAND MARKET ANALYSIS BY GENDER |
    82. 6.79 THAILAND MARKET ANALYSIS BY AGE GROUP |
    83. 6.80 INDONESIA MARKET ANALYSIS BY TYPE |
    84. 6.81 INDONESIA MARKET ANALYSIS BY END USER |
    85. 6.82 INDONESIA MARKET ANALYSIS BY CATEGORY |
    86. 6.83 INDONESIA MARKET ANALYSIS BY GENDER |
    87. 6.84 INDONESIA MARKET ANALYSIS BY AGE GROUP |
    88. 6.85 REST OF APAC MARKET ANALYSIS BY TYPE |
    89. 6.86 REST OF APAC MARKET ANALYSIS BY END USER |
    90. 6.87 REST OF APAC MARKET ANALYSIS BY CATEGORY |
    91. 6.88 REST OF APAC MARKET ANALYSIS BY GENDER |
    92. 6.89 REST OF APAC MARKET ANALYSIS BY AGE GROUP |
    93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
    94. 6.91 BRAZIL MARKET ANALYSIS BY TYPE |
    95. 6.92 BRAZIL MARKET ANALYSIS BY END USER |
    96. 6.93 BRAZIL MARKET ANALYSIS BY CATEGORY |
    97. 6.94 BRAZIL MARKET ANALYSIS BY GENDER |
    98. 6.95 BRAZIL MARKET ANALYSIS BY AGE GROUP |
    99. 6.96 MEXICO MARKET ANALYSIS BY TYPE |
    100. 6.97 MEXICO MARKET ANALYSIS BY END USER |
    101. 6.98 MEXICO MARKET ANALYSIS BY CATEGORY |
    102. 6.99 MEXICO MARKET ANALYSIS BY GENDER |
    103. 6.100 MEXICO MARKET ANALYSIS BY AGE GROUP |
    104. 6.101 ARGENTINA MARKET ANALYSIS BY TYPE |
    105. 6.102 ARGENTINA MARKET ANALYSIS BY END USER |
    106. 6.103 ARGENTINA MARKET ANALYSIS BY CATEGORY |
    107. 6.104 ARGENTINA MARKET ANALYSIS BY GENDER |
    108. 6.105 ARGENTINA MARKET ANALYSIS BY AGE GROUP |
    109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE |
    110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CATEGORY |
    112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENDER |
    113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP |
    114. 6.111 MEA MARKET ANALYSIS |
    115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TYPE |
    116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY CATEGORY |
    118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY GENDER |
    119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP |
    120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TYPE |
    121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY CATEGORY |
    123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY GENDER |
    124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP |
    125. 6.122 REST OF MEA MARKET ANALYSIS BY TYPE |
    126. 6.123 REST OF MEA MARKET ANALYSIS BY END USER |
    127. 6.124 REST OF MEA MARKET ANALYSIS BY CATEGORY |
    128. 6.125 REST OF MEA MARKET ANALYSIS BY GENDER |
    129. 6.126 REST OF MEA MARKET ANALYSIS BY AGE GROUP |
    130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
    131. 6.128 RESEARCH PROCESS OF MRFR |
    132. 6.129 DRO ANALYSIS OF HEALTHCARE |
    133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
    136. 6.133 HEALTHCARE, BY TYPE, 2024 (% SHARE) |
    137. 6.134 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion) |
    138. 6.135 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    139. 6.136 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
    140. 6.137 HEALTHCARE, BY CATEGORY, 2024 (% SHARE) |
    141. 6.138 HEALTHCARE, BY CATEGORY, 2024 TO 2035 (USD Billion) |
    142. 6.139 HEALTHCARE, BY GENDER, 2024 (% SHARE) |
    143. 6.140 HEALTHCARE, BY GENDER, 2024 TO 2035 (USD Billion) |
    144. 6.141 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE) |
    145. 6.142 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion) |
    146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    147. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.2.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.3.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.4.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.5.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.6.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.7.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.8.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.9.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.10.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.11.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.12.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.13.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.14.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.15.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.16.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.17.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.18.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.19.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.20.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.21.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.22.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.23.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.24.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.25.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.26.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.27.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.28.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.29.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY CATEGORY, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY GENDER, 2025-2035 (USD Billion) | |
      5. 7.30.5 BY AGE GROUP, 2025-2035 (USD Billion) |
    177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    178. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Pharmacological Treatments
  • Non-Pharmacological Treatments
  • Surgical Interventions

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Clinics
  • Homecare Settings

Healthcare By Category (USD Billion, 2025-2035)

  • Overactive Bladder Medications
  • Neuromodulation Devices
  • Supportive Therapies

Healthcare By Gender (USD Billion, 2025-2035)

  • Male
  • Female

Healthcare By Age Group (USD Billion, 2025-2035)

  • Children
  • Adults
  • Elderly

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions